Bach-Rojecky L - Search Results

1

Resolving Issues About Efficacy and Safety of Low-Dose Codeine in Combination Analgesic Drugs: A Systematic Review.

Ćelić I, Bach-Rojecky L, Merćep I, Soldo A, Petrak AK, Bučan A. Ćelić I, et al. Among authors: bach rojecky l. Pain Ther. 2020 Jun;9(1):171-194. doi: 10.1007/s40122-020-00162-8. Epub 2020 Mar 14. Pain Ther. 2020. PMID: 32172479 Free PMC article. Review.

2

Role of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region.

Drinovac Vlah V, Filipović B, Bach-Rojecky L, Lacković Z. Drinovac Vlah V, et al. Eur J Pain. 2018 Mar;22(3):583-591. doi: 10.1002/ejp.1146. Epub 2017 Nov 13. Eur J Pain. 2018. PMID: 29134730

3

The antidepressant activity of Hypericum perforatum L. measured by two experimental methods on mice.

Bach-Rojecky L, Kalodjera Z, Samarzija I. Bach-Rojecky L, et al. Acta Pharm. 2004 Jun;54(2):157-62. Acta Pharm. 2004. PMID: 15274759

4

What have we learned about antinociceptive effect of botulinum toxin type A from mirror-image pain models?

Drinovac Vlah V, Bach-Rojecky L. Drinovac Vlah V, et al. Among authors: bach rojecky l. Toxicon. 2020 Oct 15;185:164-173. doi: 10.1016/j.toxicon.2020.07.014. Epub 2020 Jul 19. Toxicon. 2020. PMID: 32698026 Review.

5

Botulinum toxin type A in experimental neuropathic pain.

Bach-Rojecky L, Relja M, Lacković Z. Bach-Rojecky L, et al. J Neural Transm (Vienna). 2005 Feb;112(2):215-9. doi: 10.1007/s00702-004-0265-1. J Neural Transm (Vienna). 2005. PMID: 15657640

6

Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain.

Bach-Rojecky L, Lacković Z. Bach-Rojecky L, et al. Croat Med J. 2005 Apr;46(2):201-8. Croat Med J. 2005. PMID: 15849840 Free article.

7

[Botulinum toxin type A and cholinergic system].

Bach-Rojecky L, Relja M, Filipović B, Lacković Z. Bach-Rojecky L, et al. Lijec Vjesn. 2007 Dec;129(12):407-14. Lijec Vjesn. 2007. PMID: 18383744 Review. Croatian.

8

Lack of anti-inflammatory effect of botulinum toxin type A in experimental models of inflammation.

Bach-Rojecky L, Dominis M, Lacković Z. Bach-Rojecky L, et al. Fundam Clin Pharmacol. 2008 Oct;22(5):503-9. doi: 10.1111/j.1472-8206.2008.00615.x. Epub 2008 Aug 20. Fundam Clin Pharmacol. 2008. PMID: 18717739

9

Central origin of the antinociceptive action of botulinum toxin type A.

Bach-Rojecky L, Lacković Z. Bach-Rojecky L, et al. Pharmacol Biochem Behav. 2009 Dec;94(2):234-8. doi: 10.1016/j.pbb.2009.08.012. Epub 2009 Sep 2. Pharmacol Biochem Behav. 2009. PMID: 19732788

10

Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection.

Bach-Rojecky L, Salković-Petrisić M, Lacković Z. Bach-Rojecky L, et al. Eur J Pharmacol. 2010 May 10;633(1-3):10-4. doi: 10.1016/j.ejphar.2010.01.020. Epub 2010 Feb 1. Eur J Pharmacol. 2010. PMID: 20123097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters